Contact Us
Global Natural Killer (NK) Cell Therapeutics Market Report 2025

Natural Killer (NK) Cell Therapeutics Global Market Report 2025 - By Therapeutics (Natural Killer (NK) Cell Directed Antibodies, Natural Killer (NK) Cell Therapies ), By Application (Immunoproliferative Disorders, Gastrointestinal Diseases, Cancer, Other Applications), By Distribution Channel (Hospital Pharmacies, Direct Tender, Other Distribution Channels ), By End User (Research And Academic Institutes, Hospitals, Specialty Clinics) - Market Size, Trends, And Global Forecast 2025-2034

Natural Killer (NK) Cell Therapeutics Global Market Report 2025

Report Price : $4490.00 | Pages : 200 | Published : June 2025 | Delivery Time: 2-3 business days Info | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Natural Killer (NK) Cell Therapeutics Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Natural Killer (NK) Cell Therapeutics Market?

Natural Killer (NK) cell therapeutics are treatments that harness or enhance NK cells, a type of immune cell, to target and destroy cancer cells, infected cells, or other diseased cells. These therapies include NK cell infusions (autologous/allogeneic), CAR-NK cells (genetically modified to target specific proteins), and NK-directed antibodies (bispecific antibodies).

The main therapeutics of natural killer (nk) cell therapeutics are NK cell-directed antibodies and NK cell-based therapies. NK cell-directed antibodies are engineered to boost the ability of NK cells to recognize and eliminate cancer cells by targeting tumor-specific antigens. These therapies are applied for various applications such as cancer, immunoproliferative disorders, gastrointestinal diseases, and others. Distribution channels include hospital pharmacies, direct tenders, and others, while end-users primarily consist of hospitals, specialty clinics, and research and academic institutes.

Natural Killer (NK) Cell Therapeutics Market Size and growth rate 2025 to 2029: Graph

What Is The Natural Killer (NK) Cell Therapeutics Market Size 2025 And Growth Rate?

The natural killer (NK) cell therapeutics market size has grown rapidly in recent years. It will grow from $3.52 billion in 2024 to $3.96 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to rise in cancer incidence, increase in R&D funding, growth in awareness of immunotherapy, rise in strategic industry partnerships, rise in regulatory support, and improvements in cell expansion technologies.

What Is The Natural Killer (NK) Cell Therapeutics Market Growth Forecast?

The natural killer (NK) cell therapeutics market size is expected to see rapid growth in the next few years. It will grow to $6.3 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to rising clinical trials, rising investment in immunotherapy R&D, expanding applications in solid tumors, strategic collaborations, regulatory support for cell therapies, and growing patient demand for personalized cancer treatments. Major trends in the forecast period include innovations in genetic engineering, improved CAR-NK therapies, enhanced cell expansion techniques, innovation in clinical trial activity, development of off-the-shelf NK cell products, and advancements in solid tumor treatments

How Is The Natural Killer (NK) Cell Therapeutics Market Segmented?

The natural killer (NK) cell therapeutics market covered in this report is segmented –

1) By Therapeutics: Natural Killer (NK) Cell Directed Antibodies, Natural Killer (NK) Cell Therapies

2) By Application: Immunoproliferative Disorders, Gastrointestinal Diseases, Cancer, Other Applications

3) By Distribution Channel: Hospital Pharmacies, Direct Tender, Other Distribution Channels

4) By End User: Research And Academic Institutes, Hospitals, Specialty Clinics

Subsegments:

1) By Natural Killer (NK) Cell Directed Antibodies: monoclonal antibodies (mabs), Bispecific Antibodies (BsAbs), Antibody-Drug Conjugates (ADCs)

2) By Natural Killer (NK) Cell Therapies: Autologous NK Cell Therapies, Allogeneic NK Cell Therapies, Chimeric Antigen Receptor (CAR)-NK Cell Therapies

What Is Driving The Natural Killer (NK) Cell Therapeutics Market? Rising Cancer Prevalence Fueling The Growth Due To Increasing Demand For Targeted Immunotherapies

The rising prevalence of cancer are expected to propel the growth of the natural killer (NK) cell therapeutics market going forward. Cancer refers to diseases where abnormal cells grow uncontrollably, invade nearby tissues, and spread to other body parts. It disrupts normal cell regulation, forming tumors and impairing bodily functions. Environmental exposures to pollutants, tobacco smoke, and chemicals can damage deoxyribonucleic acid (DNA) and disrupt cellular function, increasing cancer risk. Natural killer (NK) cell therapeutics help treat cancer by directly targeting and destroying tumor cells without prior sensitization. For instance, in April 2024, according to American Cancer Society, a US-based non-profit organization, reported that in 2022, 20 million cancer cases were newly diagnosed and 9.7 million people died from the disease worldwide. By 2050, the number of cancer cases is predicted to increase to 35 million based solely on projected population growth. Therefore, the rising prevalence of cancer is driving the growth of natural killer (NK) cell therapeutics market.

Who Are The Major Players In The Global Natural Killer (NK) Cell Therapeutics Market?

Major companies operating in the natural killer (NK) cell therapeutics market are Sanofi S.A., Thermo Fisher Scientific, Lonza AG, Catalent, Kite Pharma, Fate Therapeutics, Artiva Biotherapeutics, Nkarta, Inc, Celularity Inc., NKGen Biotech, Dragonfly Therapeutics, Cytovia Therapeutics, Glycostem Therapeutics, Gamida Cell, ONK Therapeutics, Wugen Inc., AGC Biologics, CytoImmune Therapeutics, XNK Therapeutics, Indapta Therapeutics, Neukio Biotherapeutics, Senti Biosciences, WuXi Advanced Therapies, Kiadis Pharma

What Are The Key Trends Of The Global Natural Killer (NK) Cell Therapeutics Market? Advancements In Scalable iPSC-Based Manufacturing For Off-The-Shelf NK Cell Therapies

Major companies operating in the natural killer (NK) cell therapeutics market are focusing on advancements such as developing scalable iPSC-based NK cell manufacturing platforms, to enable cost-effective, off-the-shelf NK cell therapies. These platforms utilize induced pluripotent stem cells (iPSCs) to generate NK cells in a standardized, feeder-free, and closed-system bioreactor environment, ensuring high yields and regulatory compliance. For instance, in April 2025, Cellistic, a Belgium-based biotechnology research company, launched the Echo-NK platform, an iPSC-based manufacturing solution for NK cell therapies. The platform offers scalable production of NK cells targeting blood cancers, solid tumors, and autoimmune diseases, with all critical expansion steps performed in bioreactor closed systems within Cellistic's EMA-certified GMP facility. By integrating Cellistic's Pulse cell line development capabilities and proprietary STAR-CRISPR technology, the Echo-NK platform accelerates timelines for developing stable iPSC cell lines with specific gene edits, providing a commercially viable solution for off-the-shelf NK cell therapies.

What Are Latest Mergers And Acquisitions In The Natural Killer (NK) Cell Therapeutics Market? AstraZeneca’s Acquisition Of EsoBiotec Boosting Cell Therapy Capabilities Due To Strategic Expansion In Cancer Therapeutics

In March 2025, AstraZeneca, a British-Swedish multinational pharmaceutical and biotechnology company, acquired EsoBiotec for up to $1 billion, with an initial payment of $425 million and up to $575 million in milestone-based contingent payments. AstraZeneca aims to leverage EsoBiotec’s platform to make cell therapies more accessible, scalable, and affordable for cancer patients globally, marking a significant step in expanding its cell therapy portfolio. EsoBiotec is a Belgian-based biotech company operating in cell therapeutics development.

What Is The Regional Outlook For The Global Natural Killer (NK) Cell Therapeutics Market?

North America was the largest region in the natural killer (NK) cell therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the natural killer (NK) cell therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the natural killer (NK) cell therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Natural Killer (NK) Cell Therapeutics Market?

The natural killer (NK) cell therapeutics market includes revenues earned by entities by providing services such as scell therapy development, clinical trial support, contract manufacturing, regulatory consulting, and cell line engineering. The market value includes the value of related goods sold by the service provider or included within the service offering. The natural killer (NK) cell therapeutics market also includessales of cytokine-activated NK cells, CAR-NK cell therapies, cell expansion kits, reagents, and culture media. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Natural Killer (NK) Cell Therapeutics Industry?

The natural killer (nk) cell therapeutics market research report is one of a series of new reports from The Business Research Company that provides natural killer (nk) cell therapeutics market statistics, including the natural killer (nk) cell therapeutics industry global market size, regional shares, competitors with the natural killer (nk) cell therapeutics market share, detailed natural killer (nk) cell therapeutics market segments, market trends, and opportunities, and any further data you may need to thrive in the natural killer (nk) cell therapeutics industry. This natural killer (nk) cell therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Natural Killer NK Cell Therapeutics Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $3.96 billion
Revenue Forecast In 2034 $6.3 billion
Growth Rate CAGR of 12.3% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The natural killer (NK) cell therapeutics market covered in this report is segmented –
1) By Therapeutics: Natural Killer (NK) Cell Directed Antibodies, Natural Killer (NK) Cell Therapies
2) By Application: Immunoproliferative Disorders, Gastrointestinal Diseases, Cancer, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Direct Tender, Other Distribution Channels
4) By End User: Research And Academic Institutes, Hospitals, Specialty Clinics Subsegments:
1) By Natural Killer (NK) Cell Directed Antibodies: Monoclonal Antibodies (mAbs), Bispecific Antibodies (BsAbs), Antibody-Drug Conjugates (ADCs)
2) By Natural Killer (NK) Cell Therapies: Autologous NK Cell Therapies, Allogeneic NK Cell Therapies, Chimeric Antigen Receptor (CAR)-NK Cell Therapies
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Sanofi S.A., Thermo Fisher Scientific, Lonza AG, Catalent, Kite Pharma, Fate Therapeutics, Artiva Biotherapeutics, Nkarta, Inc, Celularity Inc., NKGen Biotech, Dragonfly Therapeutics, Cytovia Therapeutics, Glycostem Therapeutics, Gamida Cell, ONK Therapeutics, Wugen Inc., AGC Biologics, CytoImmune Therapeutics, XNK Therapeutics, Indapta Therapeutics, Neukio Biotherapeutics, Senti Biosciences, WuXi Advanced Therapies, Kiadis Pharma
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Natural Killer (NK) Cell Therapeutics Market Characteristics

    3. Natural Killer (NK) Cell Therapeutics Market Trends And Strategies

    4. Natural Killer (NK) Cell Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

    5. Global Natural Killer (NK) Cell Therapeutics Growth Analysis And Strategic Analysis Framework

    5.1. Global Natural Killer (NK) Cell Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Natural Killer (NK) Cell Therapeutics Market Growth Rate Analysis

    5.4. Global Natural Killer (NK) Cell Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Natural Killer (NK) Cell Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Natural Killer (NK) Cell Therapeutics Total Addressable Market (TAM)

    6. Natural Killer (NK) Cell Therapeutics Market Segmentation

    6.1. Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Natural Killer (NK) Cell Directed Antibodies

    Natural Killer (NK) Cell Therapies

    6.2. Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Immunoproliferative Disorders

    Gastrointestinal Diseases

    Cancer

    Other Applications

    6.3. Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospital Pharmacies

    Direct Tender

    Other Distribution Channels

    6.4. Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Research And Academic Institutes

    Hospitals

    Specialty Clinics

    6.5. Global Natural Killer (NK) Cell Therapeutics Market, Sub-Segmentation Of Natural Killer (NK) Cell Directed Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Monoclonal Antibodies (mAbs)

    Bispecific Antibodies (BsAbs)

    Antibody-Drug Conjugates (ADCs)

    6.6. Global Natural Killer (NK) Cell Therapeutics Market, Sub-Segmentation Of Natural Killer (NK) Cell Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Autologous NK Cell Therapies

    Allogeneic NK Cell Therapies

    Chimeric Antigen Receptor (CAR)-NK Cell Therapies

    7. Natural Killer (NK) Cell Therapeutics Market Regional And Country Analysis

    7.1. Global Natural Killer (NK) Cell Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Natural Killer (NK) Cell Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market

    8.1. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Natural Killer (NK) Cell Therapeutics Market

    9.1. China Natural Killer (NK) Cell Therapeutics Market Overview

    9.2. China Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Natural Killer (NK) Cell Therapeutics Market

    10.1. India Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Natural Killer (NK) Cell Therapeutics Market

    11.1. Japan Natural Killer (NK) Cell Therapeutics Market Overview

    11.2. Japan Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Natural Killer (NK) Cell Therapeutics Market

    12.1. Australia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Natural Killer (NK) Cell Therapeutics Market

    13.1. Indonesia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Natural Killer (NK) Cell Therapeutics Market

    14.1. South Korea Natural Killer (NK) Cell Therapeutics Market Overview

    14.2. South Korea Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Natural Killer (NK) Cell Therapeutics Market

    15.1. Western Europe Natural Killer (NK) Cell Therapeutics Market Overview

    15.2. Western Europe Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Natural Killer (NK) Cell Therapeutics Market

    16.1. UK Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Natural Killer (NK) Cell Therapeutics Market

    17.1. Germany Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Natural Killer (NK) Cell Therapeutics Market

    18.1. France Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Natural Killer (NK) Cell Therapeutics Market

    19.1. Italy Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Natural Killer (NK) Cell Therapeutics Market

    20.1. Spain Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Natural Killer (NK) Cell Therapeutics Market

    21.1. Eastern Europe Natural Killer (NK) Cell Therapeutics Market Overview

    21.2. Eastern Europe Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Natural Killer (NK) Cell Therapeutics Market

    22.1. Russia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Natural Killer (NK) Cell Therapeutics Market

    23.1. North America Natural Killer (NK) Cell Therapeutics Market Overview

    23.2. North America Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Natural Killer (NK) Cell Therapeutics Market

    24.1. USA Natural Killer (NK) Cell Therapeutics Market Overview

    24.2. USA Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Natural Killer (NK) Cell Therapeutics Market

    25.1. Canada Natural Killer (NK) Cell Therapeutics Market Overview

    25.2. Canada Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Natural Killer (NK) Cell Therapeutics Market

    26.1. South America Natural Killer (NK) Cell Therapeutics Market Overview

    26.2. South America Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Natural Killer (NK) Cell Therapeutics Market

    27.1. Brazil Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Natural Killer (NK) Cell Therapeutics Market

    28.1. Middle East Natural Killer (NK) Cell Therapeutics Market Overview

    28.2. Middle East Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Natural Killer (NK) Cell Therapeutics Market

    29.1. Africa Natural Killer (NK) Cell Therapeutics Market Overview

    29.2. Africa Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Natural Killer (NK) Cell Therapeutics Market Competitive Landscape And Company Profiles

    30.1. Natural Killer (NK) Cell Therapeutics Market Competitive Landscape

    30.2. Natural Killer (NK) Cell Therapeutics Market Company Profiles

    30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Thermo Fisher Scientific  Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Lonza AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Catalent  Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Kite Pharma Overview, Products and Services, Strategy and Financial Analysis

    31. Natural Killer (NK) Cell Therapeutics Market Other Major And Innovative Companies

    31.1. Fate Therapeutics

    31.2. Artiva Biotherapeutics

    31.3. Nkarta, Inc

    31.4. Celularity Inc.

    31.5. NKGen Biotech

    31.6. Dragonfly Therapeutics

    31.7. Cytovia Therapeutics

    31.8. Glycostem Therapeutics

    31.9. Gamida Cell

    31.10. ONK Therapeutics

    31.11. Wugen Inc.

    31.12. AGC Biologics

    31.13. CytoImmune Therapeutics

    31.14. XNK Therapeutics

    31.15. Indapta Therapeutics

    32. Global Natural Killer (NK) Cell Therapeutics Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Natural Killer (NK) Cell Therapeutics Market

    34. Recent Developments In The Natural Killer (NK) Cell Therapeutics Market

    35. Natural Killer (NK) Cell Therapeutics Market High Potential Countries, Segments and Strategies

    35.1 Natural Killer (NK) Cell Therapeutics Market In 2029 - Countries Offering Most New Opportunities

    35.2 Natural Killer (NK) Cell Therapeutics Market In 2029 - Segments Offering Most New Opportunities

    35.3 Natural Killer (NK) Cell Therapeutics Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Natural Killer (NK) Cell Therapeutics Market, Sub-Segmentation Of Natural Killer (NK) Cell Directed Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Natural Killer (NK) Cell Therapeutics Market, Sub-Segmentation Of Natural Killer (NK) Cell Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Natural Killer (NK) Cell Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Natural Killer (NK) Cell Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Sanofi S.A. Financial Performance
  • Table 78: Thermo Fisher Scientific  Financial Performance
  • Table 79: Lonza AG Financial Performance
  • Table 80: Catalent  Financial Performance
  • Table 81: Kite Pharma Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Natural Killer (NK) Cell Therapeutics Market, Sub-Segmentation Of Natural Killer (NK) Cell Directed Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Natural Killer (NK) Cell Therapeutics Market, Sub-Segmentation Of Natural Killer (NK) Cell Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Natural Killer (NK) Cell Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Natural Killer (NK) Cell Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Sanofi S.A. Financial Performance
  • Figure 78: Thermo Fisher Scientific  Financial Performance
  • Figure 79: Lonza AG Financial Performance
  • Figure 80: Catalent  Financial Performance
  • Figure 81: Kite Pharma Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Natural Killer NK Cell Therapeutics market?

Natural Killer (NK) cell therapeutics are treatments that harness or enhance NK cells, a type of immune cell, to target and destroy cancer cells, infected cells, or other diseased cells. These therapies include NK cell infusions (autologous/allogeneic), CAR-NK cells (genetically modified to target specific proteins), and NK-directed antibodies (bispecific antibodies). For further insights on the Natural Killer NK Cell Therapeutics market, request a sample here

How will the Natural Killer NK Cell Therapeutics market drivers and restraints affect the market dynamics? What forces will shape the Natural Killer NK Cell Therapeutics industry going forward?

The Natural Killer NK Cell Therapeutics market major growth driver - Rising Cancer Prevalence Fueling The Growth Due To Increasing Demand For Targeted Immunotherapies. For further insights on the Natural Killer NK Cell Therapeutics market, request a sample here

What is the forecast market size or the forecast market value of the Natural Killer NK Cell Therapeutics market?

The Natural Killer NK Cell Therapeutics market size has grown strongly in recent years. The natural killer (NK) cell therapeutics market size has grown rapidly in recent years. It will grow from $3.52 billion in 2024 to $3.96 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to rise in cancer incidence, increase in R&D funding, growth in awareness of immunotherapy, rise in strategic industry partnerships, rise in regulatory support, and improvements in cell expansion technologies. The natural killer (NK) cell therapeutics market size is expected to see rapid growth in the next few years. It will grow to $6.3 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to rising clinical trials, rising investment in immunotherapy R&D, expanding applications in solid tumors, strategic collaborations, regulatory support for cell therapies, and growing patient demand for personalized cancer treatments. Major trends in the forecast period include innovations in genetic engineering, improved CAR-NK therapies, enhanced cell expansion techniques, innovation in clinical trial activity, development of off-the-shelf NK cell products, and advancements in solid tumor treatments For further insights on the Natural Killer NK Cell Therapeutics market, request a sample here

How is the Natural Killer NK Cell Therapeutics market segmented?

The natural killer (NK) cell therapeutics market covered in this report is segmented –
1) By Therapeutics: Natural Killer (NK) Cell Directed Antibodies, Natural Killer (NK) Cell Therapies
2) By Application: Immunoproliferative Disorders, Gastrointestinal Diseases, Cancer, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Direct Tender, Other Distribution Channels
4) By End User: Research And Academic Institutes, Hospitals, Specialty Clinics
Subsegments:
1) By Natural Killer (NK) Cell Directed Antibodies: Monoclonal Antibodies (mAbs), Bispecific Antibodies (BsAbs), Antibody-Drug Conjugates (ADCs)
2) By Natural Killer (NK) Cell Therapies: Autologous NK Cell Therapies, Allogeneic NK Cell Therapies, Chimeric Antigen Receptor (CAR)-NK Cell Therapies For further insights on the Natural Killer NK Cell Therapeutics market,
request a sample here

Which region has the largest share of the Natural Killer NK Cell Therapeutics market? What are the other regions covered in the report?

North America was the largest region in the natural killer (NK) cell therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the natural killer (NK) cell therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Natural Killer NK Cell Therapeutics market, request a sample here.

Who are the major players in the Natural Killer NK Cell Therapeutics market?

Major companies operating in the natural killer (NK) cell therapeutics market are Sanofi S.A., Thermo Fisher Scientific, Lonza AG, Catalent, Kite Pharma, Fate Therapeutics, Artiva Biotherapeutics, Nkarta, Inc, Celularity Inc., NKGen Biotech, Dragonfly Therapeutics, Cytovia Therapeutics, Glycostem Therapeutics, Gamida Cell, ONK Therapeutics, Wugen Inc., AGC Biologics, CytoImmune Therapeutics, XNK Therapeutics, Indapta Therapeutics, Neukio Biotherapeutics, Senti Biosciences, WuXi Advanced Therapies, Kiadis Pharma . For further insights on the Natural Killer NK Cell Therapeutics market, request a sample here.

What are the key trends in the Natural Killer NK Cell Therapeutics market?

Major trends in the Natural Killer NK Cell Therapeutics market include Advancements In Scalable iPSC-Based Manufacturing For Off-The-Shelf NK Cell Therapies. For further insights on the Natural Killer NK Cell Therapeutics market, request a sample here.

What are the major opportunities in the Natural Killer NK Cell Therapeutics market? What are the strategies for the Natural Killer NK Cell Therapeutics market?

For detailed insights on the major opportunities and strategies in the Natural Killer NK Cell Therapeutics market, request a sample here.

How does the Natural Killer NK Cell Therapeutics market relate to the overall economy and other similar markets?

For detailed insights on Natural Killer NK Cell Therapeutics's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Natural Killer NK Cell Therapeutics industry?

For detailed insights on the mergers and acquisitions in the Natural Killer NK Cell Therapeutics industry, request a sample here.

What are the key dynamics influencing the Natural Killer NK Cell Therapeutics market growth? SWOT analysis of the Natural Killer NK Cell Therapeutics market.

For detailed insights on the key dynamics influencing the Natural Killer NK Cell Therapeutics market growth and SWOT analysis of the Natural Killer NK Cell Therapeutics industry, request a sample here.